NeuroPace (NPCE) Deferred Taxes (2020 - 2021)
NeuroPace (NPCE) posted quarterly Deferred Taxes of -$47000.0 for Q4 2021, down 122.27% year-over-year from $211000.0 in Q4 2020, and little changed quarter-over-quarter from -$47000.0 in Q3 2021.
NeuroPace (NPCE) Deferred Taxes (2020 - 2021) Analysis & Trends
NeuroPace's Deferred Taxes history runs 2 years deep, the most recent figure standing at -$47000.0 for Q4 2021.
- In Q4 2021, Deferred Taxes fell 122.27% year-over-year to -$47000.0; the TTM figure through Sep 2022 stood at -$47000.0 (up 84.74% YoY), while the FY2021 annual figure was -$566000.0, down 4616.67% from the prior year.
- Deferred Taxes for Q4 2021 stood at -$47000.0, roughly flat from -$47000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $211000.0 in Q4 2020, with the low at -$294000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 107.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 17.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -181.30 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -300,000.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 235.96 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 600,000.00 |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -47,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Jun 30, 2021 | -294,000.00 |
| Mar 31, 2021 | -178,000.00 |
| Dec 31, 2020 | 211,000.00 |
| Sep 30, 2020 | -44,000.00 |
| Jun 30, 2020 | -105,000.00 |
| Mar 31, 2020 | -74,000.00 |